-
Comparing Costs of At-Home Colorectal Screening TestsCologuard and FIT have been found equally effective at screening for colorectal cancer and are widely used, but FIT is a fraction of the cost of Cologuard.
by Jon Kelvey
-
Women Less Satisfied With Cancer CareCompared with men, women’s initial cancer symptoms are less likely to be taken seriously.
by Sandra Gordon
-
From the Editor-in-Chief
Taking Aim at CancerTherapeutic antibodies carry ‘payloads’ to destroy cancer cells.
by William G. Nelson, MD, PhD
-
Forward Look
Treating Brain MetastasesNeurologist David Schiff discusses the significance of new evidence-based guidance on how to treat brain metastases from solid tumors.
by Kendall K. Morgan
-
Forward Look
Many Online Pharmacies Are IllegitimatePatients looking for online discounts for drugs should proceed with caution.
by Eric Fitzsimmons
-
Forward Look
Losing HeartCardiovascular mortality rates for survivors of early-stage Hodgkin lymphoma outpace cancer-related mortality.
by Marci A. Landsmann
-
Forward Look
Cancer Clinical Trials May Get a Boost From TelehealthRemote approaches would remove barriers, potentially improving patient participation and diversity.
by Stephen Ornes
-
Mysterious MicrobesScientists look to decode the role of intestinal bacteria in our responses to immunotherapy.
by Natalie Slivinski
-
Healthy Habits
Vital VeggiesAllium vegetables, such as garlic and onions, contain a compound that may lower the risk for several cancers.
by Erin O'Donnell
-
Capivasertib Extends Progression-Free Survival in Hormone Receptor-Positive Breast CancerThe new AKT inhibitor doubled progression-free survival when added to treatment with Faslodex.
by Eric Fitzsimmons
Reports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
